Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1975 Sep;21(3):384–393.

Serum lymphocytotoxins in inflammatory bowel disease. Studies of frequency and specificity for lymphocyte subpopulations.

R G Strickland, E M Friedler, C A Henderson, I D Wilson, R D Williams Jr
PMCID: PMC1538304  PMID: 1081934

Abstract

Serum cold-reactive lymphocytotoxin (LCT) was detected in twenty-two of fifty-six (40%) patients with inflammatory bowel disease (IBD). The frequency of LCT detection was similar in Crohn's disease and ulcerative colitis. Cytotoxicity testing against T or B cell-enriched peripheral blood lymphocytes from normal donors, together with absorption experiments, indicated that LCT in IBD was reactive against determinants on both cell subpopulations. Reactivity against T cells from patients with common variable immunodeficiency was significantly less than with normal donor T cells. LCT in IBD could not be related to prior allogeneic sensitization and its presence appeared to be unrelated to disease activity or drug therapy. No correlation was found between LCT and peripheral blood T- or B-cell numbers. The present findings suggest the need for further investigation of the role of infectious agents in the pathogenesis of IBD.

Full text

PDF
384

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cave D. R., Mitchell D. N., Kane S. P., Brooke B. N. Further animal evidence of a transmissible agent in Crohn's disease. Lancet. 1973 Nov 17;2(7838):1120–1122. doi: 10.1016/s0140-6736(73)90936-7. [DOI] [PubMed] [Google Scholar]
  2. Goldberg L. S., Cunningham J. E., Terasaki P. I. Lymphocytotoxins and pernicious anemia. Blood. 1972 Jun;39(6):862–865. [PubMed] [Google Scholar]
  3. Greaves M. F., Brown G. Purification of human T and B lymphocytes. J Immunol. 1974 Jan;112(1):420–423. [PubMed] [Google Scholar]
  4. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kamin R. M., Henry C., Fudenberg H. H. Suppressor cells in the rabbit appendix. J Immunol. 1974 Oct;113(4):1151–1161. [PubMed] [Google Scholar]
  6. Knapp W., Pateisky K. Lymphocytotoxins in myasthenia gravis. Z Immunitatsforsch Exp Klin Immunol. 1972 Dec;144(4):329–334. [PubMed] [Google Scholar]
  7. Korsmeyer S., Strickland R. G., Wilson I. D., Williams R. C., Jr Serum lymphocytotoxic and lymphocytophilic antibody activity in inflammatory bowel disease. Gastroenterology. 1974 Oct;67(4):578–583. [PubMed] [Google Scholar]
  8. Kreisler M. J., Hirata A. A., Terasaki P. I. Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination. Transplantation. 1970 Nov;10(5):411–415. [PubMed] [Google Scholar]
  9. Kreisler M., Naito S., Terasaki P. I. Cytotoxins in disease. V. Various diseases. Transplant Proc. 1971 Mar;3(1):112–114. [PubMed] [Google Scholar]
  10. Kuwert E., Bertrams J. Leukocyte iso- and autoantibodies in multiple sclerosis (MS) with special regard to complement-dependent cold-reacting auto-lymphocytotoxins (CoCoCy). Eur Neurol. 1972;7(1):65–73. doi: 10.1159/000114413. [DOI] [PubMed] [Google Scholar]
  11. Lies R. B., Messner R. P., Williams R. C., Jr Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus. Arthritis Rheum. 1973 May-Jun;16(3):369–375. doi: 10.1002/art.1780160312. [DOI] [PubMed] [Google Scholar]
  12. Mitchell D. N., Rees R. J. Agent transmissible from Crohn's disease tissue. Lancet. 1970 Jul 25;2(7665):168–171. doi: 10.1016/s0140-6736(70)92532-8. [DOI] [PubMed] [Google Scholar]
  13. Naito S., Mickey M. R., Hirata A., Terasaki P. I. Autolymphocytotoxins following immunization by pregnancy, transplantation, and disease. Tissue Antigens. 1971;1(5):219–228. doi: 10.1111/j.1399-0039.1971.tb00099.x. [DOI] [PubMed] [Google Scholar]
  14. Ooi B. S., Orlina A. R., Masaitis L., First M. R., Pollak V. E. Lymphocytotoxins in aging. Transplantation. 1974 Aug;18(2):190–192. [PubMed] [Google Scholar]
  15. Ooi B. S., Orlina A. R., Masaitis L. Lymphocytotoxins in primary renal disease. Lancet. 1974 Dec 7;2(7893):1348–1350. doi: 10.1016/s0140-6736(74)92215-6. [DOI] [PubMed] [Google Scholar]
  16. Pernis B., Forni L., Amante L. Immunoglobulin spots on the surface of rabbit lymphocytes. J Exp Med. 1970 Nov;132(5):1001–1018. doi: 10.1084/jem.132.5.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Strickland R. G., Korsmeyer S., Soltis R. D., Wilson I. D., Williams R. C., Jr Peripheral blood T and B cells in chronic inflammatory bowel disease. Gastroenterology. 1974 Oct;67(4):569–577. [PubMed] [Google Scholar]
  18. Söltoft J., Petersen L., Kruse P. Immunoglobulin deficiency and regional enteritis. Scand J Gastroenterol. 1972;7(3):233–236. doi: 10.3109/00365527209181158. [DOI] [PubMed] [Google Scholar]
  19. Terasaki P. I., Mottironi V. D., Barnett E. V. Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med. 1970 Oct 1;283(14):724–728. doi: 10.1056/NEJM197010012831403. [DOI] [PubMed] [Google Scholar]
  20. Thomas D. B. Antibodies to membrane antigen(s) common to thymocytes and a subpopulation of lymphocytes in infectious-mononucleosis sera. Lancet. 1972 Feb 19;1(7747):399–403. doi: 10.1016/s0140-6736(72)90854-9. [DOI] [PubMed] [Google Scholar]
  21. Thomas D. B., Phillips B. Evidence for membrane antigen(s) specific for human B lymphoblasts. Clin Exp Immunol. 1973 May;14(1):91–96. [PMC free article] [PubMed] [Google Scholar]
  22. Waldmann T. A., Durm M., Broder S., Blackman M., Blaese R. M., Strober W. Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet. 1974 Sep 14;2(7881):609–613. doi: 10.1016/s0140-6736(74)91940-0. [DOI] [PubMed] [Google Scholar]
  23. Weeke B., Bendixen G. Serum immunoglobulins and organ-specific, cellular hypersensitivity in ulcerative colitis and Crohn's disease. Acta Med Scand. 1969 Jul-Aug;186(1-2):87–91. doi: 10.1111/j.0954-6820.1969.tb01444.x. [DOI] [PubMed] [Google Scholar]
  24. Wernet P., Kunkel H. G. Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions. J Exp Med. 1973 Oct 1;138(4):1021–1026. doi: 10.1084/jem.138.4.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wigzell H., Sundqvist K. G., Yoshida T. O. Separation of cells according to surface antigens by the use of antibody-coated columns. Fractionation of cells carrying immunoglobulins and blood group antigen. Scand J Immunol. 1972;1(1):75–87. doi: 10.1111/j.1365-3083.1972.tb03737.x. [DOI] [PubMed] [Google Scholar]
  26. Williams R. C., Jr, Emmons J. D., Yunis E. J. Studies of human sera with cytotoxic activity. J Clin Invest. 1971 Jul;50(7):1514–1524. doi: 10.1172/JCI106637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Winchester R. J., Winfield J. B., Siegal F., Wernet P., Bentwich Z., Kunkel H. G. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies. J Clin Invest. 1974 Nov;54(5):1082–1092. doi: 10.1172/JCI107852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wybran J., Carr M. C., Fudenberg H. H. The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest. 1972 Oct;51(10):2537–2543. doi: 10.1172/JCI107069. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES